JP Morgan Chase’s SELLAS Life Sciences SLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$328K	Buy	81,824 +32,345	+65%	+$145K	﹤0.01%	5235
2025 Q4	$187K	Buy	49,479 +8,757	+22%	+$17K	﹤0.01%	5577
2025 Q3	$65.6K	Sell	40,722 -21,170	-34%	-$37.7K	﹤0.01%	6123
2025 Q2	$136K	Buy	+61,892	New	+$95K	﹤0.01%	5458
2024 Q4	–	Sell	-5,789	Closed	-$7.24K	–	7700
2024 Q3	$7.24K	Buy	+5,789	New	+$7.08K	﹤0.01%	6422
2024 Q2	–	Sell	-6,092	Closed	-$6.15K	–	7715
2024 Q1	$6.15K	Sell	6,092 -3,701	-38%	-$3.11K	﹤0.01%	6411
2023 Q4	$10.4K	Buy	9,793 +5,759	+143%	+$6.23K	﹤0.01%	6391
2023 Q3	$6.62K	Buy	4,034 +2,034	+102%	+$3.21K	﹤0.01%	6329
2023 Q2	$3.14K	Buy	+2,000	New	+$3.21K	﹤0.01%	6270
2022 Q4	–	Sell	-3,550	Closed	-$7K	–	6956
2022 Q3	$7K	Hold	3,550	–	–	﹤0.01%	6041
2022 Q2	$8K	Buy	+3,550	New	+$10.4K	﹤0.01%	6076
2021 Q3	–	Sell	-876	Closed	-$10K	–	6766
2021 Q2	$10K	Buy	+876	New	+$8.55K	﹤0.01%	6037
2017 Q2	–	Sell	-14	Closed	-$13K	–	5196
2017 Q1	$13K	Buy	14 +4	+40%	+$6.62K	﹤0.01%	4774
2016 Q4	$29K	Buy	+10	New	+$58.1K	﹤0.01%	4640